Author

Nir Wasserberg

MUCUS COMPOSITION ALTERATIONS IN INFLAMMATORY BOWEL DISEASES (IBD)
MUCUS COMPOSITION ALTERATIONS IN INFLAMMATORY BOWEL DISEASES (IBD)

Nir Wasserberg  et al.

MUCUS COMPOSITION ALTERATIONS IN INFLAMMATORY BOWEL DISEASES
MUCUS COMPOSITION ALTERATIONS IN INFLAMMATORY BOWEL DISEASES

Nir Wasserberg  et al.

PATIENTS WITH NEWLY DIAGNOSED FISTULIZING PERIANAL CROHN'S DISEASE HAVE DISTINCT MICROBIAL SIGNATURE
PATIENTS WITH NEWLY DIAGNOSED FISTULIZING PERIANAL CROHN'S DISEASE HAVE DISTINCT MICROBIAL SIGNATURE

Nir Wasserberg  et al.

RESPONSIVENESS OF FECAL CALPROTECTIN AND QUALITY OF LIFE QUESTIONNAIRES TO CHANGE IN POUCH DISEASE ACTIVITY. RESULTS FROM A PROSPECTIVE TRIAL
RESPONSIVENESS OF FECAL CALPROTECTIN AND QUALITY OF LIFE QUESTIONNAIRES TO CHANGE IN POUCH DISEASE ACTIVITY. RESULTS FROM A PROSPECTIVE TRIAL

Nir Wasserberg  et al.

HUMAN INTESTINAL EPITHELIAL CELLS INTERNALIZE LUMINAL FUNGI VIA LC3-ASSOCIATED PHAGOCYTOSIS
HUMAN INTESTINAL EPITHELIAL CELLS INTERNALIZE LUMINAL FUNGI VIA LC3-ASSOCIATED PHAGOCYTOSIS

Nir Wasserberg  et al.

RISK FACTORS AND EFFICACY OF BIOLOGIC THERAPY FOLLOWING ILEAL POUCH-ANAL ANASTOMOSIS AMONG PATIENTS WITH ULCERATIVE COLITIS: LONG-TERM DATA FROM A PROSPECTIVE COHORT
RISK FACTORS AND EFFICACY OF BIOLOGIC THERAPY FOLLOWING ILEAL POUCH-ANAL ANASTOMOSIS AMONG PATIENTS WITH ULCERATIVE COLITIS: LONG-TERM DATA FROM A PROSPECTIVE COHORT

Nir Wasserberg  et al.

Item 1 - 6 / 6
1